San Diego – BioMed Realty, a provider of real estate solutions to the life science and technology industries, announced the promotion of four officers in support of the company’s continued expansion and investment in core innovation markets.
Allyn Aguirre has been named senior vice president, accounting and treasury after serving as vice president, senior controller. Her increased role encompasses overseeing the company’s in-house accounting, tax, treasury and financial reporting functions. She joined BioMed in 2011 and has contributed to the company’s acquisitions and capital markets transactions. Prior to BioMed, Aguirre was an audit manager at KPMG LLP, where she served global real estate clients in San Diego and Sydney, Australia.
Maria Huntalas has been named vice president, corporate communications & marketing after serving as senior director, corporate communications & marketing. She has direct oversight of BioMed Realty’s corporate communications and marketing efforts, including brand awareness, media relations and various corporate and property marketing initiatives. Her specific expertise in digital and data-driven marketing strategies has resulted in increasing the company’s competitive share of voice and elevating BioMed Realty’s brand and reputation among tenants, investors and the community. Prior to BioMed, Huntalas held strategic marketing roles at IBM for over 20 years.
Lan Nguyen was named vice president, risk management after serving as senior director, risk management. She has direct oversight of the global risk programs and safety for BioMed Realty’s operating portfolio and in-process developments. She has achieved premium savings through integrated risk and safety programs for BioMed’s operations and assets since 2018. Nguyen has also implemented a company risk management information system to improve operations and maintain tenant satisfaction. Prior to BioMed, she held risk management roles in the air transportation and energy industries.
Emily Yu has been elevated to vice president, legal after serving as managing attorney, legal. She will take on an increased leadership role within BioMed’s legal team, which covers the entire BioMed portfolio. Since joining BioMed in 2015, Yu has contributed to acquisition, disposition, leasing, development and financing transactions for the East Coast and U.K. markets. Prior to BioMed, she served as counsel at Locke Lord LLP, specializing in commercial real estate transactions.